Primary Category:
Treatment Protocols
Disease Category:
Genitourinary, Renal, Renal Metastatic
Status:
Open, Temporarily Closed
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Eligible for screening study DCP 001
NCT#03793166
A031704, Step 1 new patient registration, is temporarily suspended effective March 8, 2010
